114 related articles for article (PubMed ID: 2301589)
1. Differing actions of dietary protein and enalapril on renal function and proteinuria.
Hutchison FN; Martin VI; Jones H; Kaysen GA
Am J Physiol; 1990 Jan; 258(1 Pt 2):F126-32. PubMed ID: 2301589
[TBL] [Abstract][Full Text] [Related]
2. Modulation of albuminuria by dietary protein and converting enzyme inhibition.
Hutchinson FN; Schambelan M; Kaysen GA
Am J Physiol; 1987 Oct; 253(4 Pt 2):F719-25. PubMed ID: 2821830
[TBL] [Abstract][Full Text] [Related]
3. Albuminuria causes lysozymuria in rats with Heymann nephritis.
Hutchison FN; Kaysen GA
Kidney Int; 1988 Apr; 33(4):787-91. PubMed ID: 2838679
[TBL] [Abstract][Full Text] [Related]
4. Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome.
Hutchison FN; Martin VI
Am J Physiol; 1990 May; 258(5 Pt 2):F1237-44. PubMed ID: 1692447
[TBL] [Abstract][Full Text] [Related]
5. Effect of dietary protein and enalapril on proximal tubular delivery and absorption of albumin in nephrotic rats.
Fitzgibbon WR; Webster SK; Imamura A; Ploth DW; Hutchison FN
Am J Physiol; 1996 Jun; 270(6 Pt 2):F986-96. PubMed ID: 8764318
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis.
Kaysen GA; Davies RW; Hutchison FN
Kidney Int Suppl; 1989 Nov; 27():S154-62. PubMed ID: 2561514
[TBL] [Abstract][Full Text] [Related]
7. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Hutchinson FN; Webster SK
Am J Physiol; 1992 Aug; 263(2 Pt 2):F311-8. PubMed ID: 1510124
[TBL] [Abstract][Full Text] [Related]
8. Branched-chain amino acids augment neither albuminuria nor albumin synthesis in nephrotic rats.
Kaysen GA; al-Bander H; Martin VI; Jones H; Hutchison FN
Am J Physiol; 1991 Feb; 260(2 Pt 2):R177-84. PubMed ID: 1996710
[TBL] [Abstract][Full Text] [Related]
9. High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms.
Kaysen GA; Webster S; Al-Bander H; Jones H; Hutchison FN
Miner Electrolyte Metab; 1998; 24(4):238-45. PubMed ID: 9554562
[TBL] [Abstract][Full Text] [Related]
10. High protein diets stimulate albumin synthesis at the site of albumin mRNA transcription.
Kaysen GA; Jones H; Hutchison FN
Kidney Int Suppl; 1989 Nov; 27():S168-72. PubMed ID: 2561516
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
12. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
[TBL] [Abstract][Full Text] [Related]
13. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Diamond JR; Anderson S
Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein intake on lifelong changes in renal function of rats unilaterally nephrectomized at young age.
Provoost AP; De Keijzer MH; Molenaar JC
J Lab Clin Med; 1989 Jul; 114(1):19-26. PubMed ID: 2738445
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibition delays development of terminal renal failure in the presence of severe albuminuria.
Verseput GH; Koomans HA; Braam B; Weening JJ; Provoost AP
Am J Kidney Dis; 2000 Feb; 35(2):202-10. PubMed ID: 10676717
[TBL] [Abstract][Full Text] [Related]
16. A low-protein diet restricts albumin synthesis in nephrotic rats.
Kaysen GA; Jones H; Martin V; Hutchison FN
J Clin Invest; 1989 May; 83(5):1623-9. PubMed ID: 2708523
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A
Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802
[TBL] [Abstract][Full Text] [Related]
18. In vivo visualization of the antialbuminuric effects of the angiotensin-converting enzyme inhibitor enalapril.
Schießl IM; Kattler V; Castrop H
J Pharmacol Exp Ther; 2015 May; 353(2):299-306. PubMed ID: 25680709
[TBL] [Abstract][Full Text] [Related]
19. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
Guron G
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
[TBL] [Abstract][Full Text] [Related]
20. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
Kaysen GA; Davies RW
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
